CT
Celmatix Therapeutics
Biotechnology · New York, New York, United States · Founded 2009About
They have a first-in-class oral fsh receptor agonist, a novel jnk inhibitor for endometriosis, and early-stage amh-targeting antibodies.
Company details may include data from People Data Labs, licensed CC BY 4.0.